ACADIA Pharmaceuticals Inc. (ACAD) fell -7.08% or -2.05 to $26.91. It is approximately 1.90 million shares traded, which is 102.68% compare to the average total volume 1.85 million. The market cap of ACAD is $3.34 billion. The year to date change is -4.83%. The 52 week price range is from $25.06 to $41.2. Price of ACAD have changed -8.76% during last week. It have changed 0.21% over last month, -11.03% over last 3 months, -5.27% over last 6 months and -23.49% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACAD is 29.26. It is 8.73% above current price. The 200-day Moving Averages for ACAD is 31.14. It is 15.72% above current price. The 52-week High is 41.2. It is 53.10% from the current price. The 52-week Low is 25.06. It is -6.87% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ACAD is 6.95 on 2018-01-12. Short % to float is 9.58%. There are some statistics of ACAD. It is has market cap $3.34 billion. The share outstanding is 124.21 million. The average volume is 1.85 million. The revenue is 93.30M. The gross profit is 84.98M. The percent of top 15 Institution holding is 97.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACAD is -62.64%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACAD is -58.04%.